共 112 条
[1]
Martin DA(2013)The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings J Invest Dermatol 133 17-26
[2]
Towne JE(2013)Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis Clin Cosmet Investig Dermatol 6 233-44
[3]
Kricorian G(2013)Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice PLoS One 8 2097-104
[4]
Weidemann AK(2014)Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis Mol Med Rep 9 E3422-31
[5]
Crawshaw AA(2014)IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms Proc Natl Acad Sci 111 2757-67
[6]
Byrne E(2014)IL-19 Is a Component of the Pathogenetic IL-23/IL-17 Cascade in Psoriasis J Invest Dermatol 134 462-9
[7]
Sun J(2012)IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice J Immunol 188 728-35
[8]
Zhao Y(2014)IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions J Invest Dermatol 134 133-42
[9]
Hu J(2014)Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis Immunology 141 615-20
[10]
Qin S(2014)Interleukin-22: A likely target for treatment of autoimmune diseases Autoimmun Rev 13 699-706